Related Experiment Videos
Host response to Pseudomonas aeruginosa
1Department of General and Environmental Hygiene, University of Tubingen, FRG.
Abstract:
Patients with cystic fibrosis (CF) do not reveal a primary immune defect and respond with high numbers of functional polymorphonuclear leukocytes (PMN) and specific antibodies to lung infection with Pseudomonas aeruginosa. The mucoid character of P. aeruginosa, an altered epithelial cell surface, and high concentrations of PMN-derived lysosomal enzymes contribute to impaired bacterial lung clearance and result in chronic infection. Released PMN-elastase inactivates exotoxin A, the major toxin of P. aeruginosa, thus reducing its virulence. The imbalance between PMN-proteinases and their inhibitors leads to lung tissue damage, impaired opsonophagocytosis, and T-cell and B-cell imbalance. New therapeutical concepts in CF therefore combine anti-inflammatory drugs with effective antibiotics.
Insights
Patients with cystic fibrosis (CF) exhibit a robust immune response to Pseudomonas aeruginosa lung infections. However, bacterial factors and immune responses lead to chronic infections and lung damage, necessitating new therapeutic strategies.
Area of Science:
- Immunology
- Microbiology
- Pulmonology
Background:
- Cystic Fibrosis (CF) patients mount significant immune responses to Pseudomonas aeruginosa lung infections.
- Despite this, impaired bacterial clearance leads to chronic infection and lung damage.
Purpose of the Study:
- To elucidate the complex interplay between P. aeruginosa virulence factors and host immune responses in CF lung infections.
- To identify mechanisms contributing to chronic infection and therapeutic targets.
Main Methods:
- Analysis of immune cell function (polymorphonuclear leukocytes - PMN) and antibody responses in CF patients.
- Assessment of bacterial factors (mucoid P. aeruginosa) and host-derived enzymes (PMN-elastase) in infection dynamics.
- Evaluation of the balance between proteinases and inhibitors in host tissue damage.
Main Results:
- High numbers of functional PMN and specific antibodies are present, but bacterial factors and PMN-derived enzymes hinder clearance.
- PMN-elastase inactivates P. aeruginosa exotoxin A, reducing bacterial virulence.
- Imbalance between proteinases and inhibitors causes lung tissue damage, impaired opsonophagocytosis, and immune cell imbalance.
Conclusions:
- Therapeutic strategies for CF should address both anti-inflammatory needs and effective antibiotic treatment.
- Understanding the host-pathogen immune interactions is crucial for managing chronic P. aeruginosa infections in CF.